room. 2017-03-29, 17:00
Number of hits: 7
OS1-1 | Millan, Olga MONITORING miRNA-155-5p EXPRESSION AS BIOMARKER OF PROGNOSIS AND DIAGNOSIS OF ACUTE REJECTION IN LIVER AND RENAL TRANSPLANT RECIPIENTS |
OS1-2 | Ramirez Bajo, Maria Jose BONE MARROW MESENCHYMAL STEM CELLS BUT NOT THEIR EXTRACELLULAR VESICLES IMPROVE KIDNEY GRAFT OUTCOME IN A MODEL OF CHRONIC MIXED CELLULAR AND HUMORAL REJECTION IN RAT. Maria Jose Ramirez Bajo, Jordi Rovira, Marta Lazo-Rodriguez, Elisenda Banon-Maneus, Valeria Tubita, Daniel Moya-Rull, Natalia Hierro-Garcia, Ignacio Revuelta, Pedro Ventura , Federico Oppenheimer, Josep M Campistol , Fritz Diekmann |
OS1-3 | Crespo, Gonzalo MiRNA 181a AND 148a PLASMA LEVELS DURING ACUTE CELLULAR REJECTION IN LIVER TRANSPLANTATION () (1)Liver Transplant Unit, Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Barcelona, Spain, (2)Pharmacology and Toxicology, Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Spain, (3)Pathology Department, Hospital Clinic, Barcelona, Spain |
OS1-4 | Javier, Gimeno-Beltrán IMPACT OF THE NEW EVALUATION OF GLOMERULITIS ACCORDING TO BANFF 2013 CLASSIFICATION OF ANTIBODY-MEDIATED REJECTION () (1)Department of Pathology, Hospital del Mar, Barcelona, Spain, (2)Department of Nephrology, Hospital del Mar, Barcelona, Spain |
OS1-5 | Crespo, Marta COMPLEMENT-BINDING DONOR-SPECIFIC ANTIBODIES, ACUTE REJECTION AND KIDNEY GRAFT LOSS: C3D BETTER THAN C1Q () (1)Department of Nephrology, Hospital del Mar, Barcelona, Spain, (2)Department of Pathology, Hospital del Mar, Barcelona, Spain, (3)Reference Laboratory, Hospital del Mar, Barcelona, Spain |
OS1-6 | Redondo, Dolores OUTCOMES OF KIDNEY TRANSPLANTATION IN PATIENTS WITH PREFORMED, CLEARED OR PERSISTENT, HLA DONOR-SPECIFIC ANTIBODIES () (1)Department of Nephrology, Hospital del Mar, Barcelona, Spain, (2)Department of Pathology, Hospital del Mar, Barcelona, Spain, (3)Reference Laboratory, Hospital del Mar, Barcelona, Spain, (4)Department of Immunology, Hospital del Mar, Barcelona, Spain |
OS1-7 | Perez Riba, Merce IDENTIFICATION OF NOVEL NON-PEPTIDIC INHIBITORS OF NFATc SIGNALING AS POWERFUL TOOLS FOR IMMUNOSUPPRESSIVE THERAPY |